Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients
- 294 Downloads
Background and aim
Colorectal cancer (CRC) is one of the most rapidly increasing cancers in Korea, but no comprehensive analysis has been performed to speculate the genetic basis of CRC development. We investigated the presence of adenomatous polyposis coli gene (APC), Kirsten-ras (K-ras), p53, microsatellite instability (MSI), and melanoma antigen gene (MAGE) alterations in CRC and correlated the results obtained with clinical data.
Materials and methods
We collected 78 cancer tissues from CRC patients. Genetic analyses were performed on APC, K-ras, p53, and MSI (BAT 25 and BAT 26), and in addition, MAGE expression was tested by reverse transcription polymerase chain reaction. Correlations between genetic markers and clinical factors were analyzed after reviewing medical records.
The positive rates for alterations of APC, K-ras, p53, MSI, and MAGE in 78 tissue samples were 33.3, 29.5, 34.6, 9.0, and 68.4%, respectively. Mutations were frequently detected in codons 1291 and 1450 of APC, in codon 12 of K-ras and in codons 248, 282, and 176 of p53. APC mutations were frequently noted in early-stage cancer, whereas MSI was observed in right-sided and multiple cancers. No associations were found between the presence of alterations in APC, K-ras, p53, MSI, and MAGE.
In Koreans, positive rates of alterations in APC and p53 were slightly lower than those of APC and p53 in Caucasians, and the genetic alterations including MAGE expression are involved in 92.1% of CRCs. The lack of multiple mutations and of a relation between mutation rates and clinical stage suggest that genetic alterations might have independent influences on CRC development in Koreans.
KeywordsColorectal neoplasm APC K-ras p53 MAGE
This work was equally supported by two research funds. (The Korean Institute of Industrial Technology Evaluation and Planning through the Biomolecular Engineering Center at Kyungpook National University and grant no. RTI04-03-01 from the Regional Technology Innovation Program of the Ministry of Commerce, Industry and Energy).
- 3.Kim JP, Park IS, Ahn YO, Shin MH, Ahn DH, Kang TW, Ko UR, Ku PS, Kim KY, Kim KH, Kim NK, Kim DJ, Kim DH, Kim BS, Kim SH, Park CT, Min JS, Park TK, Woo BH, Yoo H, Lee SW, Lee SJ, Cho KS, Joo HZ, Ham EK (1995) 1991 Cancer incidence in Seoul, Korea: results of the implementation study of the Seoul cancer registry. J Korean Med Sci 10:74–84PubMedGoogle Scholar
- 5.Suh CI, Suh KA, Park SH, Chang HJ, Ko JW, Ahn DH (2000) Annual report of the central cancer registry in Korea—1998. J Korean Cancer Assoc 32:827–834Google Scholar
- 6.Shin HR, Jung KW, Won YJ, Park JG (2004) 2002 Annual report of the Korea central cancer registry: based on registered data from 139 hospitals. Cancer Res Treat 36:93–99Google Scholar
- 7.Vogelstein B, Kinzler KW (2002) The genetic basis human cancer. In: Kinzler KW, Vogelstin B (eds) Colorectal cancers. McGraw-Hill, New York, pp 587–593Google Scholar
- 12.Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, Smet C, Brasseur F, Bruggen P, Lethe B, Lurquin C, Brasseur R, Chomez P, Backer O, Cavenee W, Boon T (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40:360–369PubMedCrossRefGoogle Scholar
- 14.Kim KH, Choi JS, Kim IJ, Ku JL, Park JG (2006) Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues. World J Gastroenterol 21:5651–5657Google Scholar
- 23.Luijt RB, Khan PM, Vasen HFA, Tops CMJ, Leeuwen-Cornelisse ISJ, Wijnen JT, Klift HM, Plug RJ, Griffioen G, Fodde G (1997) Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern Analysis. Human Mutat 9:7–16CrossRefGoogle Scholar
- 25.Oh HE, Cho SJ, Won NH, Lee D, Kim I, Yeom BW (2001) K-ras gene mutations and expression of K-ras, p16, cyclin D1 and p53 in synchronous lesions of the colon adenoma carcinoma sequences. Korean J Pathol 35:291–298Google Scholar
- 28.Alves PM, Levy N, Bouzourene H, Viatte S, Bricard G, Ayyoub M, Vuilleumier H, Givel JC, Halkic N, Speiser DE, Romero P, Levy F (2007) Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer. Cancer Immunol Immunother 56:839–847PubMedCrossRefGoogle Scholar
- 33.Cravo ML, Fidalgo PO, Lage PA, Albuquerque CM, Chaves PP, Claro I, Gomes T, Gaspar C, Soares JO, Nobre-Leitao C (1999) Validation and simplification of Bethesda guidelines for identifying apparently sporadic forms of colorectal carcinoma with microsatellite instability. Cancer 85:779–785PubMedCrossRefGoogle Scholar